Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.

Antonin Levy,Lizza E L Hendriks,Cécile Le Péchoux, Sally Falk,Benjamin Besse,Silvia Novello,Anne-Marie C Dingemans,Baktiar Hasan,Martin Reck,Thierry Berghmans,Corinne Faivre-Finn

Lung Cancer（2019）

引用 18|浏览28

暂无评分

摘要

•198 responses (56% radiation oncologists) to this European survey were analysed.•OD RT is the most commonly used regimen.•BD RT increased after the CONVERT trial publication (32% before; 42% after).•Future research questions: integrating systemic therapies, and PCI vs MRI surveillance.

查看译文

关键词

Small-cell lung cancer,Limited-stage,Thoracic radiotherapy,Fractionation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要